MURFREESBORO, Tenn.--(BUSINESS WIRE)--
National Health Investors, Inc. (NYSE:NHI) announced today its
Normalized Funds From Operations (“FFO”), its Normalized Adjusted Funds
From Operations (“AFFO”), its Normalized Funds Available for
Distribution (“FAD”) and net income attributable to common stockholders
for the three months and year ended December 31, 2014.
2014 Highlights
-
Normalized FFO per diluted common share increased by 15.4% over 2013;
Normalized AFFO increased 9.3% over 2013
-
Over $571 million in real estate and loan investments completed during
2014
-
Subsequent to year end, completed or announced $209.5 million of new
investments
Financial Results
-
Normalized FFO per diluted common share for the three months ended
December 31, 2014 was $1.06, an increase of 15.2% over the same period
in the prior year. Normalized FFO per diluted common share for the
year ended December 31, 2014, was $4.20, an increase of 15.4% over the
same period in the prior year.
-
Normalized AFFO per diluted common share for the three months ended
December 31, 2014 was $0.94, an increase of 10.6% over the same period
in the prior year. Normalized AFFO per diluted common share for the
year ended December 31, 2014 was $3.75, an increase of 9.3% over the
same period in the prior year.
-
Normalized FAD per diluted common share for the three months ended
December 31, 2014 was $0.95, an increase of 10.5% over the same period
in the prior year. Normalized FAD for the year ended December 31,
2014, was $3.81, an increase of 8.5% over the same period in the prior
year.
-
FFO per diluted common share for the three months ended December 31,
2014, was $1.07, an increase of 4.9% over the same period in the prior
year. FFO per diluted common share for the year ended December 31,
2014, was $4.15, an increase of 13.4% over the same period in the
prior year.
-
Net income attributable to common stockholders per diluted common
share for the three months ended December 31, 2014, was $0.80, a
decrease of 14.0% over the same period in the prior year. Net income
attributable to common stockholders per diluted common share for the
year ended December 31, 2014, was $3.04, a decrease of 18.7% over the
same period in the prior year. Net income for 2013 included the impact
of gains and other income from discontinued operations.
Normalized FFO, Normalized AFFO and Normalized FAD for the year ended
December 31, 2014 exclude $2,145,000 of debt issuance costs written off
as a result of modifications to our unsecured credit facility,
$1,655,000 of unamortized debt premium recognized into income upon the
payoff of two Fannie Mae mortgages and a $932,000 non-cash write-off of
straight-line rent receivables as part of our agreement to transition a
group of four properties to a new operator.
See our Form 8-K dated May 5, 2014 which describes changes to our
previously reported metrics as a result of our revised interpretation of
FFO. FFO, as defined by the National Association of Real Estate
Investment Trusts ("NAREIT") and applied by us, is net income (computed
in accordance with GAAP), excluding gains (or losses) from sales of real
estate property, plus real estate depreciation and amortization, and
after adjustments for unconsolidated partnerships and joint ventures, if
any.
The Company defines Normalized FFO as FFO adjusted for infrequent or
unpredictable items detailed in the reconciliations. We define
Normalized AFFO as Normalized FFO excluding the effects of straight-line
lease revenue, amortization of debt issuance costs and the non-cash
amortization of the original issue discount of our unsecured convertible
notes. The Company defines Normalized FAD as Normalized AFFO excluding
the effect of non-cash compensation expense.
The reconciliation of net income attributable to common stockholders to
our FFO, Normalized FFO, Normalized AFFO and Normalized FAD is included
as a table to this press release and filed in the Company's Form 10-K
with the Securities and Exchange Commission.
2015 Guidance
The Company currently expects Normalized FFO for 2015 to be in the range
of $4.52 to $4.58 per diluted common share and Normalized AFFO to be in
the range of $4.00 to $4.04 per diluted common share. The Company's
guidance range for the full year 2015, with underlying assumptions and
timing of certain transactions, is set forth and reconciled below:
|
|
| |
|
|
|
|
Full-Year
| | |
2015
|
| | | |
Range
|
| | | |
Low
|
|
|
High
|
|
Net income per diluted share attributable to common stockholders
| | | |
$
|
3.19
| | | |
$
|
3.22
| |
|
Plus: Depreciation
| | | |
1.33
|
| | |
1.36
|
|
| Normalized FFO per diluted common share | | | | $ | 4.52 | | | | $ | 4.58 | |
|
Less: Straight-line rental income
| | | |
(0.60
|
)
| | |
(0.62
|
)
|
|
Plus: Amortization of debt issuance costs
| | | |
0.05
| | | |
0.05
| |
|
Plus: Amortization of original issue discount
| | | |
0.03
|
| | |
0.03
|
|
| Normalized AFFO per diluted common share | | | | $ | 4.00 |
| | | $ | 4.04 |
|
| | |
|
The Company’s guidance range reflects the existence of volatile economic
conditions, but does not assume any material deterioration in tenant
credit quality and/or performance of its portfolio. The Company does not
include an estimate of investment volume in its guidance range. The
guidance is based on a number of assumptions, many of which are outside
the Company’s control and all of which are subject to change. The
Company’s guidance range allows for the uncertainty inherent in the
structure and timing of the financing required to fund previously
announced investments. The Company’s guidance may change if actual
results vary from these assumptions.
Investor Conference Call and Webcast
NHI will host a conference call on Tuesday, February 17, 2015, at 1 p.m.
ET, to discuss fourth quarter results. The number to call for this
interactive teleconference is (212) 231-2930 with the confirmation
number, 21761236. The live broadcast of NHI's fourth quarter conference
call will be available online at www.nhireit.com.
The online replay will follow shortly after the call and continue for
approximately 90 days.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a
real estate investment trust specializing in sale-leaseback,
joint-venture, mortgage and mezzanine financing of need-driven and
discretionary senior housing and medical investments. NHI’s portfolio
consists of independent, assisted and memory care communities,
entrance-fee retirement communities, skilled nursing facilities, medical
office buildings and specialty hospitals.
Visit www.nhireit.com
for more information.
Statements in this press release that are not historical facts are
forward-looking statements. NHI cautions investors that any
forward-looking statements may involve risks and uncertainties and are
not guarantees of future performance. All forward-looking statements
represent NHI's judgment as of the date of this release.Investors
are urged to carefully review and consider the various disclosures made
by NHI in its periodic reports filed with the Securities and Exchange
Commission, including the risk factors and other information disclosed
in NHI's Annual Report on Form 10-K for the most recently ended fiscal
year. Copies of these filings are available at no cost on the SEC's web
site at www.sec.gov
or on NHI's web site at www.nhireit.com.
|
|
| Reconciliation of FFO, Normalized FFO, Normalized AFFO and
Normalized FAD |
| (in thousands, except share and per share amounts) |
|
|
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
| | | | December 31,
| | | December 31,
|
| | | |
2014
|
|
|
2013
| | |
2014
|
|
|
2013
|
|
Net income attributable to common stockholders
| | | |
$
|
27,530
| | | |
$
|
27,776
| | | |
$
|
101,609
| | | |
$
|
106,183
| |
|
Elimination of certain non-cash items in net income:
| | | | | | | | | | | | | | | | | |
|
Depreciation in continuing operations
| | | |
9,705
| | | |
5,897
| | | |
38,078
| | | |
20,101
| |
|
Depreciation related to noncontrolling interest
| | | |
(260
|
)
| | |
(234
|
)
| | |
(1,002
|
)
| | |
(634
|
)
|
|
Depreciation in discontinued operations
| | | |
—
| | | |
56
| | | |
—
| | | |
557
| |
|
Net gain on sales of real estate
| | | |
—
|
| | |
(2,888
|
)
| | |
—
|
| | |
(22,258
|
)
|
|
Funds from operations
| | | |
$
|
36,975
| | | |
$
|
30,607
| | | |
138,685
| | | |
103,949
| |
|
Investment gains
| | | |
—
| | | |
(3,256
|
)
| | |
—
| | | |
(3,256
|
)
|
|
Debt issuance costs expensed due to credit facility modifications
| | | |
—
| | | |
63
| | | |
2,145
| | | |
416
| |
|
Write-off of unamortized debt premium
| | | |
(1,655
|
)
| | |
—
| | | |
(1,655
|
)
| | |
—
| |
|
Non-cash write-off of straight-line rent receivable
| | | |
932
| | | |
—
| | | |
932
| | | |
—
| |
|
Acquisition costs under business combination accounting
| | | |
89
| | | |
—
| | | |
89
| | | |
208
| |
|
Loan impairment and recoveries of previous write-downs
| | | |
—
|
| | |
—
|
| | |
—
|
| | |
1,976
|
|
|
Normalized FFO
| | | |
$
|
36,341
| | | |
$
|
27,414
| | | |
140,196
| | | |
103,293
| |
|
Straight-line lease revenue, net
| | | |
(3,771
|
)
| | |
(2,152
|
)
| | |
(16,463
|
)
| | |
(6,560
|
)
|
|
Non-cash write-off of straight-line rent receivable
| | | |
(932
|
)
| | |
—
| | | |
(932
|
)
| | |
—
| |
|
Straight-line lease revenue, net, related to noncontrolling interest
| | | |
24
| | | |
27
| | | |
71
| | | |
55
| |
|
Amortization of original issue discount
| | | |
269
| | | |
—
| | | |
798
| | | |
—
| |
|
Amortization of debt issuance costs
| | | |
520
|
| | |
110
|
| | |
1,782
|
| | |
663
|
|
|
Normalized AFFO
| | | |
32,451
| | | |
25,399
| | | |
125,452
| | | |
97,451
| |
|
Non-cash stock based compensation
| | | |
223
|
| | |
253
|
| | |
2,020
|
| | |
2,339
|
|
|
Normalized FAD
| | | |
32,674
|
| | |
25,652
|
| | |
$
|
127,472
|
| | |
$
|
99,790
|
|
| | | | | | | | | | | | | | | | |
|
BASIC | | | | | | | | | | | | | | | | | |
|
Weighted average common shares outstanding
| | | |
34,343,706
| | | |
29,831,176
| | | |
33,375,966
| | | |
28,362,398
| |
|
FFO per common share
| | | |
$
|
1.08
| | | |
$
|
1.03
| | | |
$
|
4.16
| | | |
$
|
3.67
| |
|
Normalized FFO per common share
| | | |
$
|
1.06
| | | |
$
|
.92
| | | |
$
|
4.20
| | | |
$
|
3.64
| |
|
Normalized AFFO per common share
| | | |
$
|
.94
| | | |
$
|
.85
| | | |
$
|
3.76
| | | |
$
|
3.44
| |
|
Normalized FAD per common share
| | | |
$
|
.95
| | | |
$
|
.86
| | | |
$
|
3.82
| | | |
$
|
3.52
| |
| | | | | | | | | | | | | | | | |
|
DILUTED | | | | | | | | | | | | | | | | | |
|
Weighted average common shares outstanding
| | | |
34,402,969
| | | |
29,860,614
| | | |
33,416,014
| | | |
28,397,702
| |
|
FFO per common share
| | | |
$
|
1.07
| | | |
$
|
1.02
| | | |
$
|
4.15
| | | |
$
|
3.66
| |
|
Normalized FFO per common share
| | | |
$
|
1.06
| | | |
$
|
.92
| | | |
$
|
4.20
| | | |
$
|
3.64
| |
|
Normalized AFFO per common share
| | | |
$
|
.94
| | | |
$
|
.85
| | | |
$
|
3.75
| | | |
$
|
3.43
| |
|
Normalized FAD per common share
| | | |
$
|
.95
| | | |
$
|
.86
| | | |
$
|
3.81
| | | |
$
|
3.51
| |
|
|
See Notes to Reconciliation of FFO, Normalized FFO, Normalized AFFO
and Normalized FAD.
NOTE: FFO per diluted common share for the years ended December 31, 2013
and 2012 differs by $.08 and $.06, respectively, from the amounts
previously reported as a result of our revised interpretation of the
NAREIT definition of FFO. Normalized FFO per diluted common share for
the years ended December 31, 2013 and 2012 differs by $.09 and $.05,
respectively, from the amounts previously reported in our periodic
filings as a result of our revised interpretation of the NAREIT
definition of FFO. Normalized AFFO per diluted common share for the
years ended December 31, 2013 and 2012 differ by $.10 and $.07,
respectively, from the amounts previously reported as a result of our
revised interpretation of the NAREIT definition of FFO. Normalized FAD
per diluted common share for the years ended December 31, 2013 and 2012
differs by$.02 and $.01, respectively, from the amounts previously
reported as a result of changes we made to our definition of FAD. See
our Form 8-K dated May 5, 2014 which describes these revisions.
Notes to Reconciliation of FFO, Normalized FFO,
Normalized AFFO and Normalized FAD
These supplemental operating performance measures may not be comparable
to similarly titled measures used by other REITs. Consequently, our
Funds From Operations ("FFO"), Normalized FFO, Normalized Adjusted Funds
From Operations ("AFFO") and Normalized Funds Available for Distribution
("FAD") may not provide a meaningful measure of our performance as
compared to that of other REITs. Since other REITs may not use our
definition of these operating performance measures, caution should be
exercised when comparing our Company's FFO, Normalized FFO, Normalized
AFFO and Normalized FAD to that of other REITs. These financial
performance measures do not represent cash generated from operating
activities in accordance with generally accepted accounting principles
("GAAP") (these measures do not include changes in operating assets and
liabilities) and therefore should not be considered an alternative to
net earnings as an indication of operating performance, or to net cash
flow from operating activities as determined by GAAP as a measure of
liquidity, and are not necessarily indicative of cash available to fund
cash needs.
Funds From Operations - FFO
FFO, as defined by the National Association of Real Estate Investment
Trusts ("NAREIT") and applied by us, is net income (computed in
accordance with GAAP), excluding gains (or losses) from sales of real
estate property, plus real estate depreciation and amortization, and
after adjustments for unconsolidated partnerships and joint ventures, if
any. The Company’s computation of FFO may not be comparable to FFO
reported by other REITs that do not define the term in accordance with
the current NAREIT definition or have a different interpretation of the
current NAREIT definition from that of the Company; therefore, caution
should be exercised when comparing our Company’s FFO to that of other
REITs. Diluted FFO assumes the exercise of stock options and other
potentially dilutive securities. Normalized FFO excludes from FFO
certain items which, due to their infrequent or unpredictable nature,
may create some difficulty in comparing FFO for the current period to
similar prior periods, and may include, but are not limited to,
impairment of non-real estate assets, gains and losses attributable to
the acquisition and disposition of assets and liabilities, and
recoveries of previous write-downs.
We believe that FFO and normalized FFO are important supplemental
measures of operating performance for a REIT. Because the historical
cost accounting convention used for real estate assets requires
depreciation (except on land), such accounting presentation implies that
the value of real estate assets diminishes predictably over time. Since
real estate values instead have historically risen and fallen with
market conditions, presentations of operating results for a REIT that
uses historical cost accounting for depreciation could be less
informative, and should be supplemented with a measure such as FFO. The
term FFO was designed by the REIT industry to address this issue.
Adjusted Funds From Operations - AFFO
In addition to the adjustments included in the calculation of normalized
FFO, normalized AFFO excludes the impact of any straight-line lease
revenue, amortization of the original issue discount on our convertible
senior notes and amortization of debt issuance costs.
We believe that normalized AFFO is an important supplemental measure of
operating performance for a REIT. GAAP requires a lessor to recognize
contractual lease payments into income on a straight-line basis over the
expected term of the lease. This straight-line adjustment has the effect
of reporting lease income that is significantly more or less than the
contractual cash flows received pursuant to the terms of the lease
agreement. GAAP also requires the original issue discount of our
convertible senior notes and debt issuance costs to be amortized as
non-cash adjustments to earnings. Normalized AFFO is useful to our
investors as it reflects the growth inherent in the contractual lease
payments of our real estate portfolio.
Funds Available for Distribution - FAD
In addition to the adjustments included in the calculation of normalized
AFFO, normalized FAD excludes the impact of non-cash stock based
compensation.
We believe that normalized FAD is an important supplemental measure of
operating performance for a REIT as a useful indicator of the ability to
distribute dividends to shareholders.
|
|
| Condensed Statements of Income |
| (in thousands, except share and per share amounts) |
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
| | | | December 31,
| | | December 31,
|
| | | |
2014
|
|
|
2013
| | |
2014
|
|
|
2013
|
| | | | | | | | | | | |
|
|
Revenues:
| | | | | | | | | | | | | | | | | |
|
Rental income
| | | |
$
|
42,944
| | | |
$
|
29,984
| | | |
$
|
166,279
| | | |
$
|
106,029
| |
|
Interest income from mortgage and other notes
| | | |
1,755
| | | |
1,756
| | | |
7,013
| | | |
7,633
| |
|
Investment income and other
| | | |
1,035
|
| | |
1,061
|
| | |
4,217
|
| | |
4,166
|
|
| | | |
45,734
|
| | |
32,801
|
| | |
177,509
|
| | |
117,828
|
|
|
Expenses:
| | | | | | | | | | | | | | | | | |
|
Depreciation
| | | |
9,705
| | | |
5,897
| | | |
38,078
| | | |
20,101
| |
|
Interest, including amortization of debt discount and issuance costs
| | | |
5,652
| | | |
3,218
| | | |
26,372
| | | |
9,229
| |
|
Legal
| | | |
60
| | | |
162
| | | |
209
| | | |
784
| |
|
Franchise, excise and other taxes
| | | |
(170
|
)
| | |
299
| | | |
620
| | | |
616
| |
|
General and administrative
| | | |
2,159
| | | |
2,084
| | | |
9,107
| | | |
9,254
| |
|
Loan and realty losses (recoveries), net
| | | |
—
|
| | |
—
|
| | |
—
|
| | |
1,976
|
|
| | | |
17,406
|
| | |
11,660
|
| | |
74,386
|
| | |
41,960
|
|
|
Income before equity-method investee, discontinued operations
| | | | | | | | | | | | | | | | | |
|
and noncontrolling interest
| | | |
28,328
| | | |
21,141
| | | |
103,123
| | | |
75,868
| |
|
Income (loss) from equity-method investee
| | | |
(227
|
)
| | |
55
| | | |
(71
|
)
| | |
324
| |
|
Investment and other gains
| | | |
—
|
| | |
3,256
|
| | |
—
|
| | |
3,306
|
|
|
Income from continuing operations
| | | |
28,101
| | | |
24,452
| | | |
103,052
| | | |
79,498
| |
|
Discontinued operations
| | | | | | | | | | | | | | | | | |
|
Income from operations - discontinued
| | | |
—
| | | |
771
| | | |
—
| | | |
5,426
| |
|
Gain on sale of real estate
| | | |
—
|
| | |
2,888
|
| | |
—
|
| | |
22,258
|
|
|
Income from discontinued operations
| | | |
—
|
| | |
3,659
|
| | |
—
|
| | |
27,684
|
|
|
Net income
| | | |
28,101
| | | |
28,111
| | | |
103,052
| | | |
107,182
| |
|
Net income attributable to noncontrolling interest
| | | |
(571
|
)
| | |
(335
|
)
| | |
(1,443
|
)
| | |
(999
|
)
|
|
Net income attributable to common stockholders
| | | |
$
|
27,530
|
| | |
$
|
27,776
|
| | |
$
|
101,609
|
| | |
$
|
106,183
|
|
| | | | | | | | | | | | | | | | |
|
|
Weighted average common shares outstanding:
| | | | | | | | | | | | | | | | | |
|
Basic
| | | |
34,343,706
| | | |
29,831,176
| | | |
33,375,966
| | | |
28,362,398
| |
|
Diluted
| | | |
34,402,969
| | | |
29,860,614
| | | |
33,416,014
| | | |
28,397,702
| |
| | | | | | | | | | | | | | | | |
|
|
Earnings per common share:
| | | | | | | | | | | | | | | | | |
|
Basic:
| | | | | | | | | | | | | | | | | |
|
Income from continuing operations attributable to common stockholders
| | | |
$
|
.80
| | | |
$
|
.81
| | | |
$
|
3.04
| | | |
$
|
2.77
| |
|
Discontinued operations
| | | |
—
|
| | |
.12
|
| | |
—
|
| | |
.97
|
|
|
Net income attributable to common stockholders
| | | |
$
|
.80
|
| | |
$
|
.93
|
| | |
$
|
3.04
|
| | |
$
|
3.74
|
|
| | | | | | | | | | | | | | | | |
|
|
Diluted:
| | | | | | | | | | | | | | | | | |
|
Income from continuing operations attributable to common stockholders
| | | |
$
|
.80
| | | |
$
|
.81
| | | |
$
|
3.04
| | | |
$
|
2.77
| |
|
Discontinued operations
| | | |
—
|
| | |
.12
|
| | |
—
|
| | |
.97
|
|
|
Net income attributable to common stockholders
| | | |
$
|
.80
|
| | |
$
|
.93
|
| | |
$
|
3.04
|
| | |
$
|
3.74
|
|
| | | | | | | | | | | | | | | | |
|
|
Regular dividends declared per common share
| | | |
$
|
.77
| | | |
$
|
.735
| | | |
$
|
3.08
| | | |
$
|
2.90
| |
|
|
|
|
| Selected Balance Sheet Data |
| (in thousands) |
|
|
|
| December 31, 2014 |
|
| December 31, 2013 |
| | | | | | | |
|
|
Real estate properties, net
| | | |
$
|
1,776,549
| | | |
$
|
1,247,740
|
|
Mortgage and other notes receivable, net
| | | |
63,630
| | | |
60,639
|
|
Investment in preferred stock, at cost
| | | |
38,132
| | | |
38,132
|
|
Cash and cash equivalents
| | | |
3,287
| | | |
11,312
|
|
Marketable securities
| | | |
15,503
| | | |
12,650
|
|
Straight-line rent receivable
| | | |
35,154
| | | |
18,691
|
|
Equity-method investment and other assets
| | | |
50,705
| | | |
66,656
|
|
Debt
| | | |
862,726
| | | |
617,080
|
|
National Health Investors Stockholders' equity
| | | |
1,039,925
| | | |
766,546
|
|
|

National Health Investors, Inc.
Roger R. Hopkins, 615-890-9100
Chief
Accounting Officer
Source: National Health Investors, Inc.